BRAIN announces €60m round of financing to expand its buy-and-build strategy

20-Nov-2012 - Germany

The supervisory board and the board of management of the biotechnology company BRAIN AG agreed on a €60m capital increase during a meeting of the supervisory board held on 19 November 2012. The capital increase helps pave the way for the implementation of BRAIN’s “buy-and-build” industrialisation strategy. A smaller share of the funds flow will serve to further advance BRAIN’S technology platforms, which play a crucial role in the NatLifE 2020 and ZeroCarb FP innovation alliances funded by the German Ministry of Education and Research (BMBF).

The largest ever round of financing in the area of white biotechnology is led by BRAIN shareholders MP Beteiligungs-GmbH (Family Office PUTSCH) based in Kaiserslautern, Germany, and MIG Fonds, one of the largest institutional investors in the area of biotechnology, and involves several other investors.

Other news from the department business & finance

More news from our other portals

All FT-IR spectrometer manufacturers at a glance